Every recall we track for Adamis Pharmaceuticals Corporation — 2 in all — plus the complaints and injury reports the public filed about them.
Adamis recalls SYMJEPI epinephrine injections due to potential needle clogging, which could prevent proper epinephrine delivery during emergencies. Affected lots expire by August 2022 and February 2023.
Adamis recalls SYMJEPI epinephrine injections due to potential needle clogging. This could prevent proper epinephrine delivery during emergencies. Check your product details and contact Adamis for instructions.
